Home / Resources and Insights / Case Study: An siRNA Drug Product IND Filing Ready in 10 Mon...
Case Study: An siRNA Drug Product IND Filing Ready in 10 Months
Less than 1 min read time
Small interfering RNA therapeutics are advanced oligonucleotide therapy. WuXi STA oligonucleotide CRDMO platform provides the integrated solution for siRNA candidates.
Related Reading
Video
Case Study: PDC Drug R&D and Manufacturing in 9 Months
Video
The Latest Progress Update on Our Middletown, DE, facility (2025)
Video
Case Study: Enable an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months
How WuXi TIDES Enabled an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months As GLP-1 receptor...